Effect of Boric Acid on a-Hydroxy Acids Compounds in Thin Layer Chromatography

Authors: Elham Moniri, Homayon Ahmad Panahi, Ahmad Izadi, Mohamad Mehdi Parvin, Atyeh Rahimi

Abstract:

In this investigation Salicylic acid, Sulfosalicylic acid and Acetyl salicylic acid were chosen as a sample for thin layer chromatography (TLC) on silica gel plates. Bicarbonate buffer at different pH containing different amounts of boric acid was applied as mobile phase. Specific interaction of these substances with boric acid has effect on Rf in thin layer chromatography. Regular and similar trend was observed in variations of Rf for mentioned compounds in TLC by altering of percentages of boric acid in mobile phase in pH range of 8-10. Also effect of organic solvent, mixture of water/ organic solvent and organic solvent containing boric acid as mobile phase was studied.

Keywords: Thin layer chromatography (TLC), Aspirin, Salicylic acid, Sulfosalycylic acid, Boric acid.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1328586

References:

[1] The Salt Collaborative Group. Lancet., vol. 388, pp. 1345-1349, 1991.
[2] M. Lecomte, O.J.C. Laneuville, D.L. Dewitt, W.L. Smith, J. Biochem., vol. 269, pp. 13207-13215, 1994.
[3] J.P. Metraux, H. Signer, J. Ryals, E. Ward, M. Wyss-Benz, G. Gaudin, K. Raschdorf, E. Schmid, W. Blum, and B. Inverardi, Science, vol. 250, pp. 1004-1006, 1990.
[4] J. Malamy, J.P. Carr, D.F. Klessig, and I. Raskin, Science, vol. 250, pp. 1002-1004, 1990.
[5] G.A. Higgs, J.A. Salmon, B. Henderson, and J.R. Vane, Proc. Natl. Acad. Sci.USA., vol. 84, pp. 1417-1420, 1987.
[6] M.J .Thun, M.M. Namboodiri, E.E. Calle, W.D. Flanders, and C.W. Heath, Cancer Res., vol. 53, pp. 122-1327, 1993.
[7] X.M. Xu, G, Sansores, A. Chenxm, B. Matijevik, N. Aleksic, P. Dum, and A.Wukk, Proc. Nati. Acad. Sci. USA, vol. 96, pp. 5292-5297, 1999.
[8] S. Dongz, B. Huangc, R.E. Brown, and Z. Mawy, J. Biol. Chem. vol. 271, pp. G 722 -G 727, 1996.
[9] N.H. Pillinger, A. Capodicic, P. Rosenthal, N. Kheterpal, B. Hanfts, M.R. Philips and G. Welssmann. Pro. Natl. Acad. Sci. USA., vol. 95, pp. 14540-14545, 1998.
[10] P. Ricchi, S. Pignata, A. Dipoplo, A.M. Memoli, A. Apicellu, R. Zarrilli, and A.M. Acquaviva, Int. J. cancer, vol. 73, pp. 880-884, 1997.
[11] P. Ricchi, T. Dimatola, A. Ruggieog , D. Zanzi, A. Apicellu, A. Dipalma, M. Pensabene, S. Pignata, R. Zarrilli, and A.M. Acquaviva, Brj. Cancer, vol. 86, pp. 1501-1509, 2002.
[12] B. K. Low, M. E. Waltner-Low, A. J. Entingh, A. Chytil, M.E. Akre, P. Norgaard, and H.L. Moses, J. Biol. Chem., vol. 275, pp. 38261-38267, 2000.
[13] P. Ricchi, A.D. Palma, T.D. Matola, A. Apicella,, R. Fortuato, R. Zarrilli and A. M. Acquaviva, Mol. Pharmacol. vol. 64, pp. 407-414, 2003.
[14] J. Kochana, A. Zakrzewska, A. Parczewski, and J. Wilamowski, J. of Liq. Chro. & Relat. Tech., vol. 28, pp. 2875-2886, 2005.
[15] J. Kochana, A. Parczewski and J. Wilamowski, J. of Liq. Chro. & Relat. Tech., vol. 29, pp. 1247-1256, 2006.